Services CMC Peptide Chemistry
Peptide Chemistry
BioDuro supports peptide programs ranging from linear sequences to complex cyclic, modified, and conjugated peptides. Synthesis and purification strategies are developed around the structure of the peptide, required quantity, target purity, and intended use.
Capabilities include solid-phase peptide synthesis (SPPS), liquid-phase peptide synthesis (LPPS), cyclization, specialized modifications, conjugation, purification, process development, and scale-up.
Peptide Synthesis Expertise
Peptide synthesis can become increasingly challenging as sequences grow longer or incorporate hydrophobic regions, unnatural amino acids, structural constraints, or specialized modifications.
BioDuro works with both standard and complex peptides, selecting the synthesis and purification approach based on the needs of each molecule. Capabilities include linear peptides up to 70 amino acids, including hindered unnatural amino acids, as well as cyclic and macrocyclic peptides, modified peptides, and peptide conjugates.
A dedicated 1,500 m² peptide synthesis center in Beijing is supported by a team of 100+ experienced chemists.
Peptide Modalities and Modifications
BioDuro supports a wide range of peptide structures, modifications, and conjugates for discovery and development programs.
Linear Peptides
- Peptides up to 70 amino acids
- Natural and unnatural amino acids
- Hindered and difficult sequences
- Hydrophobic peptides
- Cell-penetrating peptides
- TFA, acetate, and HCl salt forms
Cyclic and Macrocyclic Peptides
- Lactam-cyclized peptides
- Thioether-cyclized peptides
- Stapled peptides
- Multiple disulfide bonds
- Click-chemistry cyclization
- Cyclic lipopeptides
Modified and Special Peptides
- N- and C-terminal modifications
- Dye and fluorescent labeling
- Glycosylation
- Phosphorylation
- PEGylation
- Lipidation
- Peptidomimetics
- Peptoids and depsipeptides
Peptides Conjugates
- Peptide drug conjugates
- Metal-chelating conjugates
- Linker and payload conjugation
- Modified and multifunctional peptide constructs
Support across every stage of discovery.
BioDuro offers a full suite of medicinal chemistry services, including:
Hit Identification
The process of finding compounds that interact with a biological target, such as a protein.
Hit to Lead
Through evaluation and modification of “hit” compounds to enhance their potential.
Lead Optimization
Further refinement of a compound’s properties to develop a drug candidate.
Patent filing support
Guidance through the patent filing process for new drug compounds.
Solid-Phase and Liquid-Phase Peptide Synthesis
BioDuro offers both solid-phase peptide synthesis and liquid-phase peptide synthesis, allowing the development approach to be selected around peptide complexity, quantity, and scale-up requirements.
Solid-phase peptide synthesis capabilities extend to 800 mmol and support linear peptides, cyclic peptides, and peptide drug conjugates. Liquid-phase peptide synthesis is also available for projects where it provides a practical route to larger-scale production.
Purity and Product Options
Peptide purity requirements vary depending on whether the material will be used for initial research, biological testing, analytical standards, or later-stage development.
BioDuro offers peptide products at purity targets such as greater than 90%, 95%, and 98%, depending on sequence, complexity, scale, and intended application. Available product options include multiple salt forms and a broad range of modifications and conjugates.
Final specifications and timelines are established after reviewing the peptide sequence, required quantity, target purity, modifications, and analytical requirements.
Connected Peptide Development Services
Peptide programs can also draw on BioDuro’s Biology, DMPK, and Formulation capabilities. This allows synthesized peptides to move into biochemical and cellular testing, in vivo evaluation, developability assessment, and oral peptide formulation work when required.
BioDuro’s formulation team also supports oral peptide delivery approaches, including enteric coating and permeability-enhancement strategies.
Key instruments
Complex synthesis requires more than just standard protocols. See how our chemists navigate multi-step challenges to deliver high-purity compounds where standard solid-phase methods often fail.
PTI Symphony X
- 0.1-0.2 mmol
- N2 protection
- 24 channels
CEM MultiPep2
- 0.1-0.2 mmol
- N2 protection
- 24 channels
Tetras Volo
- 0.1-0.2 mmol
- N2 protection
- 24 channels
DL-PSI-286
- 0.1-0.2 mmol
- N2 protection
- 24 channels
Common Questions
In id sit nullam lorem pharetra scelerisque. Donec enim ac aliquet metus at nullam. Dignissim odio eget fermentum quam.
Medicinal chemistry involves designing and optimizing drug molecules to ensure that compounds are safe and effective before advancing in the development process.
Medicinal chemistry involves designing and optimizing drug molecules to ensure that compounds are safe and effective before advancing in the development process.
Medicinal chemistry involves designing and optimizing drug molecules to ensure that compounds are safe and effective before advancing in the development process.
Medicinal chemistry involves designing and optimizing drug molecules to ensure that compounds are safe and effective before advancing in the development process.
Download our full Medicinal Chemistry Fact Sheet
In posuere at eget vestibulum mi magnis cursus nulla. Massa viverra amet eget facilisis. Morbi morbi nulla sit amet lorem augue tortor.
Parallel Synthesis Services
BioDuro offers synthesis and purification services to deliver both small and large libraries, with expertise to overcome discovery stage challenges and capacity for process scale-up of drug substance.
Small libraries
- 10 – 50mg of each compound
- Purity – ≥90% (95% if desired) by HPLC/LC-MS for all compounds
- 1H-NMR for 5- 10% (or more, if required) of the compounds
Large libraries
- 10mg of each compound
- Purity – ≥85% by (90% if desired) HPLC/LC-MS for all compounds
- In general 1H-NMR for 5 – 10% of the compounds
Success in Action
Complex synthesis requires more than just standard protocols. See how our chemists navigate multi-step challenges to deliver high-purity compounds where standard solid-phase methods often fail.
42-Step Liquid-Phase Synthesis: Achieving 99% Purity
Challenge: Synthesizing the reference peptide MK-0616. Solution: Our team deployed a specialized liquid-phase strategy to overcome aggregation issues, delivering the target at >99% purity.
42-Step Liquid-Phase Synthesis: Achieving 99% Purity
Challenge: Synthesizing the reference peptide MK-0616. Solution: Our team deployed a specialized liquid-phase strategy to overcome aggregation issues, delivering the target at >99% purity.
Related Resources
Id quam odio lectus risus massa praesent. At ac quisque nec et proin adipiscing egestas proin quis. Semper id odio arcu ut augue et sagittis.
Partnership solutions
Flexible ways to engage our chemistry teams
Strategic leadership from target to candidate.
Let our project leaders drive the full DMTA cycle. We coordinate chemistry, biology, and DMPK to accelerate your path from Hit to PCC.
Dedicated scientists working exclusively on your systems.
Extend your internal capacity with a dedicated team of BioDuro-Sundia chemists working exclusively on your projects and systems.
A complete safety & tox package for regulatory submission.
streamlined transition from PCC to IND. We combine GLP-tox batch synthesis with safety assessment to get you regulatory-ready in record time.
Integrated Chemistry Services
Accelerate your discovery cycles by leveraging our full spectrum of chemistry capabilities. Whether you need parallel synthesis for library generation or computational insights for scaffold hopping, these integrated services act as force multipliers for your medicinal chemistry program.